Description
What this story covers
Aptiv's Q3 2025 10-Q: 7% sales growth to $5.2B, but a $648M impairment caused a net loss. Strategy includes EDS spin-off and Motional adjustments. Segments are resilient; liquidity supports repurchases. Risks persist in supply chains and regulations.
Story snapshot
CompanyAptiv PLC
TickerAPTV
VariantStandard detailed
Duration13:32
Filing type10-Q
PeriodQ3 2025
IndustryIndustrials & Manufacturing
Accession0001521332-25-000051
Full Story Script
Content not available for this story.
